DK0966424T3 - Aminobenzophenoner som inhibitorer for interleukin og TNF - Google Patents

Aminobenzophenoner som inhibitorer for interleukin og TNF

Info

Publication number
DK0966424T3
DK0966424T3 DK98900270T DK98900270T DK0966424T3 DK 0966424 T3 DK0966424 T3 DK 0966424T3 DK 98900270 T DK98900270 T DK 98900270T DK 98900270 T DK98900270 T DK 98900270T DK 0966424 T3 DK0966424 T3 DK 0966424T3
Authority
DK
Denmark
Prior art keywords
alkyl
content
carbamoyl
alkoxycarbonyl
trifluoromethyl
Prior art date
Application number
DK98900270T
Other languages
Danish (da)
English (en)
Inventor
Erik Rytter Ottosen
Schneur Rachlin
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of DK0966424T3 publication Critical patent/DK0966424T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98900270T 1997-01-24 1998-01-08 Aminobenzophenoner som inhibitorer for interleukin og TNF DK0966424T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9701453.4A GB9701453D0 (en) 1997-01-24 1997-01-24 Aminobenzophenones
EP98900270A EP0966424B1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf

Publications (1)

Publication Number Publication Date
DK0966424T3 true DK0966424T3 (da) 2004-11-01

Family

ID=10806523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98900270T DK0966424T3 (da) 1997-01-24 1998-01-08 Aminobenzophenoner som inhibitorer for interleukin og TNF

Country Status (19)

Country Link
US (1) US6313174B1 (enExample)
EP (1) EP0966424B1 (enExample)
JP (1) JP4250204B2 (enExample)
KR (1) KR100544046B1 (enExample)
CN (1) CN1188388C (enExample)
AT (1) ATE269844T1 (enExample)
AU (1) AU733561B2 (enExample)
CA (1) CA2278798C (enExample)
DE (1) DE69824705T2 (enExample)
DK (1) DK0966424T3 (enExample)
ES (1) ES2223116T3 (enExample)
GB (1) GB9701453D0 (enExample)
HU (1) HUP0000678A3 (enExample)
NZ (1) NZ336754A (enExample)
PL (1) PL334806A1 (enExample)
PT (1) PT966424E (enExample)
RO (1) RO120195B1 (enExample)
RU (1) RU2200153C2 (enExample)
WO (1) WO1998032730A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2379293A1 (en) * 1999-07-16 2001-01-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsa Ktieselskab) Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha.
RU2238933C2 (ru) * 1999-07-16 2004-10-27 Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) Аминобензофеноны как ингибиторы ил-1 бэта и tnf-альфа
RU2243964C2 (ru) * 1999-07-16 2005-01-10 Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) Новые аминобензофеноны
HUP0201846A3 (en) * 1999-07-16 2002-11-28 Leo Pharm Prod Ltd Amonobenzophenones as inhibitors of il-1betha and tnf-alpha and pharmaceutical compositions containing them
ES2230118T3 (es) * 1999-07-16 2005-05-01 Leo Pharma A/S Aminobenzofanonas como inhibidores de la il-1beta y tnf-alfa.
US6897236B1 (en) 1999-07-16 2005-05-24 Leo Pharmaceutical Products, Ltd. Aminobenzophenones as inhibitors of IL-1β and TNF-α
HUP0203813A3 (en) * 1999-12-06 2008-03-28 Leo Pharma As Aminobenzophenones as inhibitors of il-1betha and tnf-alpha, pharmaceutical compositions containing them and their use
EP1250332A1 (en) * 1999-12-17 2002-10-23 Abbott Laboratories Inhibitors of interleukin 5 gene expression
DE60043397D1 (de) * 1999-12-28 2010-01-07 Pharmacopeia Inc Cytokine, insbesondere tnf-alpha, hemmer
BR0111034A (pt) 2000-05-22 2003-06-17 Leo Pharma S A Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
SE0100569D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab New compounds
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
AU2002338286A1 (en) * 2001-04-10 2002-10-28 Leo Pharma A/S Novel aminophenyl ketone derivatives
JP4540984B2 (ja) 2001-08-28 2010-09-08 レオ ファーマ アクティーゼルスカブ 新規アミノベンゾフェノン
AR042634A1 (es) * 2002-12-20 2005-06-29 Leo Pharma As Compuestos de aminobenzofenona
DE602004027504D1 (de) * 2003-07-24 2010-07-15 Leo Pharma As Aminobenzophenonverbindungen
CA2590479A1 (en) * 2004-12-13 2006-06-22 Leo Pharma A/S Triazole substituted aminobenzophenone compounds
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
KR101057546B1 (ko) * 2007-06-05 2011-08-17 주식회사 엘지화학 광학 이방성 화합물 및 이를 포함하는 수지 조성물
EP2206534A1 (de) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten
WO2012167133A2 (en) * 2011-06-01 2012-12-06 The Regents Of The University Of California Inhibitors of anandamide transport and their therapeutic uses
WO2013028570A2 (en) 2011-08-19 2013-02-28 The Regents Of The University Of California Meta-substituted biphenyl peripherally restricted faah inhibitors
WO2015157313A1 (en) 2014-04-07 2015-10-15 The Regents Of The University Of California Inhibitors of fatty acid amide hydrolase (faah) enzyme with improved oral bioavailability and their use as medicaments

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535401A (en) * 1977-07-28 1978-12-13 Holliday & Co Ltd L Nitrodiphenylamine carboxylic acid disperse dyes
SU790620A1 (ru) * 1979-06-01 1981-07-30 Ордена Трудового Красного Знамени Институт Медицинскойпаразитологии И Торпической Медицины Им.E.И.Марциновского Дихлор аминобензофенон как исходный продуктдл пОлучЕНи лЕКАРСТВЕННыХ пРЕпАРАТОВ C АНТигЕльМиНТНыМдЕйСТВиЕМ
JPH0776303B2 (ja) * 1986-11-21 1995-08-16 株式会社リコー 呈色性フタリド化合物及びその製造法及びこのものを発色成分とした記録材料

Also Published As

Publication number Publication date
RU2200153C2 (ru) 2003-03-10
KR20000070437A (ko) 2000-11-25
ATE269844T1 (de) 2004-07-15
CA2278798A1 (en) 1998-07-30
HUP0000678A3 (en) 2001-11-28
HUP0000678A2 (hu) 2001-10-28
CN1248966A (zh) 2000-03-29
PT966424E (pt) 2004-09-30
ES2223116T3 (es) 2005-02-16
GB9701453D0 (en) 1997-03-12
HK1025306A1 (en) 2000-11-10
DE69824705T2 (de) 2005-07-07
JP4250204B2 (ja) 2009-04-08
EP0966424B1 (en) 2004-06-23
EP0966424A1 (en) 1999-12-29
PL334806A1 (en) 2000-03-13
NZ336754A (en) 2001-03-30
DE69824705D1 (de) 2004-07-29
RO120195B1 (ro) 2005-10-28
US6313174B1 (en) 2001-11-06
CA2278798C (en) 2007-07-03
WO1998032730A1 (en) 1998-07-30
JP2001511771A (ja) 2001-08-14
CN1188388C (zh) 2005-02-09
KR100544046B1 (ko) 2006-01-23
AU5478198A (en) 1998-08-18
AU733561B2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
DK0966424T3 (da) Aminobenzophenoner som inhibitorer for interleukin og TNF
MY158162A (en) 5-membered heterocycle-based p38 kinase inhibitors
DE60325834D1 (de) Kondensierte azabicyclischeverbindungen als inhibitoren des vanilloid-rezeptors 1 (vr1)
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
MXPA05013075A (es) Inhibidores de p-38 basados en heterociclo de 5 miembros.
MY135856A (en) Nicotinamide derivatives useful as pde4 inhibitors
MXPA05013224A (es) Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas.
DK0672031T3 (da) Catecholdiethere som selektive PDE IV-inhibitorer
MY149960A (en) 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
GB0209891D0 (en) Novel compounds
CY1116754T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις της comt
NO20071534L (no) Behandling av inflammatoriske forstyrrelser og smerte
NO20060518L (no) Pyrimidiner nyttige som modulatorer av spenningsstyrte ionekanaler
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
TW200510311A (en) CCr8 inhibitors
MY109722A (en) Azaoxindole derivatives.
TR199901917T2 (xx) 2-Amino-6-(2-ikame edilmi�-4-fenoksi)-ikame edilmi� piridinler
TW200505865A (en) Compounds useful for the treatment of diseases
AU2003278667A1 (en) Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
MXPA02011858A (es) Inhibidores de adhesion de celula mediada por alfabeta2.
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
TW200503722A (en) Substituted 7-aza-quinazoline compounds
BG108669A (en) 2-amino-6-(2,4,5-substituted-phenyl)-pyridines
SE0202279D0 (sv) Novel comppounds
SE0300906D0 (sv) Novel compounds